Invesco Dorsey Wright Healthcare Momentum ETF Rating $60.11 -0.45 (-0.74%) As of 07/2/2026 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy 2.73Holdings in PTH have an aggregate rating of Moderate Buy based on 377 analyst ratings issued in the past year covering 25 companies (62.4% of the portfolio).PTH Aggregate Price Target$60.11High Prediction$60.11Average Prediction$60.11Low Prediction$60.11Holdings in PTH have an aggregate price target of $60.11 and a range of $60.11 to $60.11 covering 25 companies (62.4% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PTH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.94%ROIVRoivant Sciences$35.131.8302 of 5 stars2.75$33.59 -4.4%12Insider Trade4.65%PRAXPraxis Precision Medicines$318.523.7085 of 5 stars2.95$569.63 78.8%213.70%TNGXTango Therapeutics$29.462.9979 of 5 stars2.73$41.50 40.9%15News CoverageInsider Trade3.35%SLSSELLAS Life Sciences Group$14.980.4191 of 5 stars2.00$10.00 -33.2%2Gap Down2.91%UTHRUnited Therapeutics$555.914.512 of 5 stars2.85$619.42 11.4%13Trending NewsInsider Trade2.89%THCTenet Healthcare$204.28+0.3%4.282 of 5 stars2.82$244.32 19.6%22Positive NewsGap Down2.74%AXSMAxsome Therapeutics$244.312.2295 of 5 stars2.95$258.95 6.0%21Insider Trade2.53%BTSGBrightSpring Health Services$69.033.8284 of 5 stars3.11$63.67 -7.8%18News CoverageAnalyst ForecastGap Up2.51%LQDALiquidia$78.933.1781 of 5 stars2.82$68.88 -12.7%112.48%MRNAModerna$79.761.1686 of 5 stars1.83$37.13 -53.4%18Gap Down2.29%ERASErasca$18.471.5414 of 5 stars2.60$20.11 8.9%10Trending NewsGap Down2.29%IONSIonis Pharmaceuticals$81.803.329 of 5 stars2.90$102.90 25.8%21Insider TradeGap Down2.23%HCAHCA Healthcare$409.99-0.1%4.6727 of 5 stars2.58$503.00 22.7%24Analyst ForecastGap Down2.21%TWSTTwist Bioscience$99.241.529 of 5 stars2.80$79.30 -20.1%10Gap Down2.08%PTGXProtagonist Therapeutics$131.621.0982 of 5 stars2.88$115.21 -12.5%16Analyst ForecastGap Down2.02%ALMSAlumis$26.502.4249 of 5 stars2.83$40.30 52.1%12News Coverage1.94%JAZZJazz Pharmaceuticals$243.473.4207 of 5 stars2.84$246.06 1.1%19Positive News1.90%LGNDLigand Pharmaceuticals$319.552.2398 of 5 stars2.88$257.71 -19.4%81.89%ORKAOruka Therapeutics$85.213.16 of 5 stars2.82$134.30 57.6%11Analyst DowngradeHigh Trading Volume1.86%CORCencora$296.430.0%4.9218 of 5 stars2.73$367.75 24.1%15News CoveragePositive NewsAnalyst DowngradeGap Down1.85%CELCCelcuity$107.952.8139 of 5 stars2.83$152.09 40.9%121.83%VTRSViatris$16.702.7908 of 5 stars2.57$17.50 4.8%71.82%INCYIncyte$116.863.9808 of 5 stars2.36$107.85 -7.7%22Options VolumeGap Down1.74%KYMRKymera Therapeutics$113.511.825 of 5 stars2.96$121.41 7.0%23Trending NewsAnalyst ForecastInsider Trade1.74%DNTHDianthus Therapeutics$94.342.2814 of 5 stars2.93$117.82 24.9%14Gap Down This page (NASDAQ:PTH) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Dorsey Wright Healthcare Momentum ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
